Farmax India Limited (FARMAXIND) Dipped -100% on Nov 15

November 15, 2017 - By Linda Rogers

Shares of Farmax India Limited (NSE:FARMAXIND) last traded at 0, representing a move of -100%, or -0.05 per share, on volume of shares. After opening the trading day at 0, shares of Farmax India Limited traded in a close range. Farmax India Limited currently has a total float of 534.17 million shares and on average sees shares exchange hands each day. The stock now has a 52-week low of 0.05 and high of 0.15.

Indian Economy’s 2 Giants

The Indian stock market is one of the fastest growing equity markets in the world today. While it currently makes up only 12% to 14% of the country’s gross domestic product (GDP)’ far from the 70% corporate sector making up the entire GDP of the US, India’s corporate sector is rampantly thriving to become one of Asia’s leaders.

As of this month, nearly 8,000 companies are listed on the Indian equity market. More than half of these are listed on the two main stock exchanges in India combined’ the Bombay Stock Exchange (BSE) and the National Stock Exchange of India (NSE), representing about 4% of the country’s GDP.

Regular session on both the BSE and the MSE starts at 9:15 a.m. and concludes at 3:30 p.m.

The BSE

The BSE, having been established in 1875, is the first stock exchange in Asia. It is also the first to acquire a permanent recognition under India’s Securities Contract Regulation Act of 1956.

Presently, the BSE is the 11th biggest stock exchange in the world with a total market capitalization of $1.70 trillion as of January 23, 2015. Moreover, it is also considered as one of the fastest stock exchanges in the world with a speed of six microseconds.

The BSE first touched its four-digit figure on July 25, 1990; the 5,000 mark on October 11, 1999; the 10,000 mark on February 6, 2006; the 20,000 mark on December 11, 2007; and the 30,000 mark on March 4, 2015, an event that was driven by the efforts of the Reserve Bank of India. Farmax India Limited is a stock traded on the Indian stock exchange.

The biggest declines on the BSE happened during the onslaught of the 2008 Global Financial Crisis and when the Chinese central bank had suddenly moved to devalue the yuan. On January 21 and 22, 2008, the BSE has lost more than 2,000 points while on August 24, 2015, it has dropped over 1,700 points.

The SENSEX 30 is the free-float index that measures the 30 most active stocks on the BSE. It weighs stocks based on liquidity, market capitalization, floating-stock-adjustment depth, and other factors.

The NSE

The NSE was founded in 1992 as the 1st demutualized electronic stock exchange in the country. Presently, it supports about 230,000 terminals throughout India. The NSE is owned and operated by the Indian Index Services and Products (IISP).

The NIFTY is the index that measures the 50 most active stocks across 24 industries on the NSE. Consequently, it covers a broader portion of India’s corporate sector than the SENSEX 30. Farmax India Limited has relatively good liquidity.

The NIFTY has a base value of 1,000 and its base date is 1995. Like the SENSEX 30, it comprehensively weighs stocks based on liquidity, market capitalization, among others.

Investing in BSE and NSE stocks is strongly recommended for investors today. As the Indian economy continues to grow and become one of Asia’s biggest, it only makes sense to start betting on its equity market as early as now. Professional analysts might be interested how this will affect Farmax India Limited.

More news for Farmax India Limited (NSE:FARMAXIND) were recently published by: Economictimes.Indiatimes.com, which released: “Mapping the market: 132 stocks at 52-week highs; midcaps, smallcaps hog limelight” on August 24, 2016. Economictimes.Indiatimes.com‘s article titled: “NSE watch: Sobha, Lakshmi Energy among stocks that declined over 4%” and published on April 10, 2017 is yet another important article.

Farmax India Limited is engaged in manufacturing and distributing of fast moving consumer goods products. The company has market cap of INR. The Firm is engaged in providing vermicelli and atta. It currently has negative earnings. The Company’s products include food products, personal care, soaps and detergents.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com